Statins May Cause Nerve Damage & increases heart disease + Class action suit

[Guest guest]

Statins May Cause Nerve Damage "Researchers showed that people taking statinswere 4 to 14 times more likely to developpolyneuropathy than those who did not takestatins. Statins include Lescol, Lipitor,Mevacor, and Pravachol. Statins are highlyeffective in preventing heart attacks, so you should not stop taking them" Here is a perfect example how the cholesterolmyth has taken a life of its own. The lack ofproof to support a link between cholesterol andheart disease does not deter the brainwashedproponents even when contrary evidence is starring them in the face. See: <http://www.newmediaexplorer.org/chris/2006/05/01/class_action_statins_increases_heart_disease_by_10_in_women.htm>ClassAction - Statins Increases Heart Disease By 10% In Women Chris Guptahttp://tinyurl.com/gclz3 See also:<http://www.newmediaexplorer.org/chris/2003/11/07/bad_news_about_statin_drugs.htm>BadNews About Statin Drugs------------------- <http://www.drmirkin.com/heart/1148.html>STATINS MAY CAUSE NERVE DAMAGE Gabe Mirkin, M.D. A Danish study reports that a small percentage ofpeople who took statin drugs for several years tolower cholesterol developed a type of nerve damage called polyneuropathy. Polyneuropathy is characterized by tingling,numbness and burning pain as well as decreasedsensitivity to temperature or pain. When a personsuffers nerve damage, a doctor is supposed tolook for a cause, such as diabetes, lack ofvitamin B12, Lyme disease, kidney disease,thyroid disease or alcohol abuse. People who hadtaken statins and developed polyneuropathies werechecked for known causes of nerve damage.Researchers showed that people taking statinswere 4 to 14 times more likely to developpolyneuropathy than those who did not takestatins. Statins include Lescol, Lipitor,Mevacor, and Pravachol. Statins are highlyeffective in preventing heart attacks, so youshould not stop taking them unless you developaside effects such as polyneuropathy. Check withyour doctor about any side effects from your medications. <http://http://www.neurology.org/cgi/content/abstract/58/9/1333>NeurologyMay 14, 2002;58:1321-1322, 1333-1337 Abstract Neurology 2002;58:1333-1337© 2002<http://www.neurology.org/cgi/content/abstract/58/9//misc/terms.shtml>AmericanAcademy of Neurology Statins and risk of polyneuropathy A case-control study D. Gaist, MD PhD, U. Jeppesen, MD PhD, M.Andersen, MD PhD, L. A. García Rodríguez, MD MSc,J. Hallas, MD PhD and S. H. Sindrup, MD PhD From the Department of Neurology (Drs. Gaist,Jeppesen, and Sindrup), Odense UniversityHospital; Epidemiology (Dr. Gaist) and ClinicalPharmacology (Drs. Andersen, Hallas, andSindrup), Institute of Public Health, Universityof Southern Denmark; and Centro Español deInvestigación Farmacoepidemiológica (Dr. García Rodríguez), Madrid, Spain. Address correspondence and reprint requests toDr. David Gaist, Epidemiology, Institute ofPublic Health, University of Southern Denmark,Sdr Boulevard 23A, 5000 Odense C, Denmark;e-mail: <dgaistdgaist or dg Background: Several case reports and a singleepidemiologic study indicate that use of statinsoccasionally may have a deleterious effect on theperipheral nervous system. The authors thereforeperformed a population-based study to estimatethe relative risk of idiopathic polyneuropathy in users of statins. Method: The authors used a population-basedpatient registry to identify first-time-evercases of idiopathic polyneuropathy registered inthe 5-year period 1994 to 1998. For each case,validated according to predefined criteria, 25control subjects were randomly selected amongsubjects from the background population matchedfor age, sex, and calendar time. The authors useda prescription register to assess exposure todrugs and estimated the odds ratio of use ofstatins (ever and current use) in cases ofidiopathic polyneuropathy compared with control subjects. Results: The authors verified a diagnosis ofidiopathic polyneuropathy in 166 cases. The caseswere classified as definite (35), probable (54),or possible (77). The odds ratio linkingidiopathic polyneuropathy with statin use was 3.7(95% CI 1.8 to 7.6) for all cases and 14.2 (5.3to 38.0) for definite cases. The correspondingodds ratios in current users were 4.6 (2.1 to10.0) for all cases and 16.1 (5.7 to 45.4) fordefinite cases. For patients treated with statinsfor 2 or more years the odds ratio of definiteidiopathic polyneuropathy was 26.4 (7.8 to 45.4). Conclusions: Long-term exposure to statins maysubstantially increase the risk of polyneuropathy. ARCHIVES: http://www.newmediaexplorer.org/chris/archives.htmShare The Wealth: http://www.newmediaexplorer.org/chris/Communication Agents: http://www.communicationagents.com/Council Member: Friends of Freedom - http://www.friendsoffreedom.org __________________